GT Biopharma is trading $6.58 (+6.50%) as broader risk-on sentiment followed August CPI data that matched expectations.
- Major indexes are higher, with the S&P 500 up 1.11% and Nasdaq up 1.19%
- The company is scheduled to host a TriKE platform webinar on September 11, but no direct causal link was reported
- Recent volatility follows the 1-for-25 reverse split effective September 8